E. Crotty et Ef. Patz, FDG-PET imaging in patients with paraneoplastic syndromes and suspected small cell lung cancer, J THOR IMAG, 16(2), 2001, pp. 89-93
Paraneoplastic syndromes may be the presenting clinical manifestation of sm
all cell lung cancer. In some cases, however, confirming the diagnosis can
be difficult because findings on conventional imaging studies can be subtle
or nonspecific. This study examined the utility of fluoro-2-deoxy-glucose
positron emission tomography (FDG-PET) in identifying clinically suspected
small cell lung cancer in patients with paraneoplastic syndromes. FDG-PET a
ppears to be very useful in localizing suspected small cell lung cancer in
patients presenting with paraneoplastic syndromes.